Skip to content

Medline

US · MDLN #667 by market cap Listed 2025
37.04 -0.80 -2.11%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Rating change
    Analysts Conflicted on These NA Names: Venture Global, Inc. Class A (VG), ServiceTitan, Inc. Class A (TTAN) and Medline (MDLN)
    TipRanks · 2026/10/8
  • Rating change
    Leerink Partners Maintains Medline(MDLN.US) With Buy Rating, Maintains Target Price $43
    Market Newswire · 2026/10/8
  • Rating change
    A Quick Look at Today's Ratings for Medline(MDLN.US), With a Forecast Between $44 to $49
    Market Newswire · 2026/11/6
  • Rating change
    Barclays Maintains Medline(MDLN.US) With Buy Rating, Maintains Target Price $43
    Market Newswire · 2026/11/4
  • Rating change
    Truist Financial Maintains Medline(MDLN.US) With Buy Rating
    Market Newswire · 2026/9/22
  • Rating change
    Bernstein Maintains Medline(MDLN.US) With Buy Rating, Cuts Target Price to $49
    Market Newswire · 2026/11/5
  • Rating change
    Leerink Partners Maintains Medline(MDLN.US) With Buy Rating, Raises Target Price to $43
    Market Newswire · 2026/9/16
  • Rating change
    William Blair Maintains Medline(MDLN.US) With Buy Rating
    Market Newswire · 2026/9/23
  • Rating change
    Mizuho Securities Maintains Medline(MDLN.US) With Buy Rating, Cuts Target Price to $45
    Market Newswire · 2026/10/22
  • Tigress Financial Maintains Medline(MDLN.US) With Buy Rating, Maintains Target Price $55
    Market Newswire · 2026/11/14
  • Rating change
    Citi Maintains Medline(MDLN.US) With Buy Rating, Cuts Target Price to $47
    Market Newswire · 2026/11/5
  • Rating change
    BofA Securities Maintains Medline(MDLN.US) With Buy Rating
    Market Newswire · 2026/11/10
  • Rating change
    Baird Maintains Medline(MDLN.US) With Buy Rating, Raises Target Price to $44
    Market Newswire · 2026/11/5
  • RBC Capital Maintains Medline(MDLN.US) With Buy Rating, Maintains Target Price $46
    Market Newswire · 2026/11/11
  • Medline Expects Offering to Close Nov. 23 MDLN
    Dow Jones · 2026/11/18
  • Rating change
    Barclays Maintains Medline(MDLN.US) With Buy Rating, Cuts Target Price to $43
    Market Newswire · 2026/10/9
  • Barclays Maintains Medline(MDLN.US) With Buy Rating, Raises Target Price to $45
    Market Newswire · 2026/11/20
  • Rating change
    UBS Maintains Medline(MDLN.US) With Buy Rating, Cuts Target Price to $43
    Market Newswire · 2026/9/25
  • Rating change
    Analysts Offer Insights on NA Companies: Ingram Micro Holding Corporation (INGM), WW International, Inc. (WW) and Medline (MDLN)
    TipRanks · 2026/9/16
  • J.P. Morgan Maintains Medline(MDLN.US) With Buy Rating, Raises Target Price to $47
    Market Newswire · 2026/11/13
  • Rating change
    Analysts Are Bullish on These NA Stocks: Medline (MDLN), Navan, Inc. Class A (NAVN)
    TipRanks · 2026/9/10
  • Rating change
    RBC Capital Maintains Medline(MDLN.US) With Buy Rating, Maintains Target Price $46
    Market Newswire · 2026/10/7
  • Rating change
    Leerink Partners Maintains Medline(MDLN.US) With Buy Rating, Cuts Target Price to $34.05
    Market Newswire · 2026/9/10
  • Rating change
    Analysts Offer Insights on NA Companies: Veeva Systems (VEEV), Blue Owl Technology Finance Corp. (OTF) and Medline (MDLN)
    TipRanks · 2026/8/27
  • Rating change
    Analysts Offer Insights on NA Companies: Alliance Laundry Holdings, Inc. (ALH) and Medline (MDLN)
    TipRanks · 2026/8/26

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Medline discussion 0 comments

Add a comment